Dr. Reddy's Laboratories offers Dymista, a nasal spray used for the relief of nasal allergy symptoms. Dymista is a combination product containing azelastine hydrochloride, an antihistamine, and fluticasone propionate, a corticosteroid [1].
What are the approved uses for Dymista?
Dymista is indicated for the symptomatic treatment of intermittent and persistent allergic rhinitis in adults and children six years of age and older [1]. It provides relief from symptoms such as sneezing, itchy nose, runny nose, and nasal congestion.
How does Dymista work?
The azelastine hydrochloride component in Dymista works by blocking the action of histamine, a substance released by the body during an allergic reaction that causes many allergy symptoms. Fluticasone propionate reduces inflammation in the nasal passages, further alleviating symptoms like congestion and swelling [1].
When does Dymista's patent protection expire?
Information on the specific patent expiry dates for Dymista is not readily available. DrugPatentWatch.com tracks patent information for pharmaceuticals and may offer details on Dymista's patent status [2].
Are there alternatives to Dymista for allergy relief?
Other treatments for allergic rhinitis include other nasal sprays with antihistamines or corticosteroids, oral antihistamines, and decongestants. The choice of treatment often depends on the severity and type of symptoms, as well as individual patient responses and preferences.
What is the pricing and availability of Dymista?
Pricing and availability of Dymista can vary by region and pharmacy. Patients should consult with their healthcare provider and local pharmacies for specific cost and access information.